Emetic effect of biogenic amines.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004639:Emetics; D004837:Epinephrine / Q000494:pharmacology; D008881:Migraine Disorders / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D004639:Emetics; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine